Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities
article has not abstract
Vyšlo v časopise:
Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities. PLoS Med 8(7): e32767. doi:10.1371/journal.pmed.1001054
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1001054
Souhrn
article has not abstract
Zdroje
1. WHO 19 July 2010 More than five million people receiving HIV treatment [press release]. Available: http://www.who.int/mediacentre/news/releases/2010/hiv_treament_20100719/en/index.html. Accessed 27 May 2011
2. Strengthening Pharmaceutical Systems (SPS) 2009 Supporting pharmacovigilance in developing countries: the systems perspective. Submitted to the U.S. Agency for International Development by the SPS Program, Management Sciences for Health. http://www.msh.org/projects/sps/SPS-Documents/upload/SPS_PV_Paper.pdf. Arlington (Virginia): Management Sciences for Health. Accessed 27 May 2011
3. OlssonSPalSStergachisACouperM 2010 An analysis of pharmacovigilance activities in 55 low- and middle income countries. Drug Safety 33 689 703
4. BissonGGrossRMillerVWellerIWalkerA 2003 Monitoring of long-term toxicities of HIV treatments: An international perspective. AIDS 17 17 2407 2417
5. Strengthening Pharmaceutical Systems (SPS) Program 2009 Indicator-based pharmacovigilance assessment tool: manual for conducting assessments in developing countries. Submitted to the U.S. Agency for International Development by the SPS Program Arlington (Virginia) Management Sciences for Health
6. PalSNWallbergMCoulterDEdwardsIRRagoL 2010 Cohort event monitoring: a WHO strategy to complement spontaneous reporting systems. Drug Safety 33 939
7. Antiretroviral Pregnancy Registry Steering Committee. 2010 Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 January 2010. Available: http://www.APRegistry.com. Accessed 27 May 2011
8. PirmohamedMAtuahKNDodooANWinstanleyP 2007 Pharmacovigilance in developing countries. BMJ 335 462
9. XuerefS 2010 Towards a global strategy on pharmacovigilance. Presented at Global Surveillance of Antiretroviral Drug Safety meeting. June 11, 2010, Washington, DC. Available: http://www.hivforum.org/storage/hivforum/documents/PV2010/pharmacovigilance%20gf%20who%20concept%20note%20may%202010.pdf. Accessed 1 June 2011
10. The Global Fund 2010 Guidelines for proposals – round 10. Section 4.8, Pharmaceutical and Other Health Products. Available: http://www.theglobalfund.org/documents/rounds/10/R10_Guidelines_Single_en.pdf. Accessed 27 May 2011
11. EdwardsIR 2010 African heat. Drug Safety 33 12 1059 1063
12. World Health Organization (WHO) 2009 A practical handbook on the pharmacovigilance of antiretroviral medicines. Available: http://www.who.int/hiv/pub/pharmacovigilance/handbook/en/index.html. Accessed 27 May 2011
13. Uppsala Monitoring Centre 2010 Monitoring Medicines. Available http://www.monitoringmedicines.org/. Accessed 27 May 2011
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 7
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Pleiotropní účinky statinů na kardiovaskulární systém
- Statiny indukovaná myopatie: Jak na diferenciální diagnostiku?
- Zástava srdce u pacienta se střelnými ranami – kazuistika
- Statinová intolerance
Najčítanejšie v tomto čísle
- Individualized Cost-Effectiveness Analysis
- GeneXpert—A Game-Changer for Tuberculosis Control?
- Screening for HIV-Associated Tuberculosis and Rifampicin Resistance before Antiretroviral Therapy Using the Xpert MTB/RIF Assay: A Prospective Study
- Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort